Following YY001 treatment, the tumor tissue exhibited increased secretion of cytokines such as CXCL9, CXCL10, and CXCL11, which contribute to the recruitment of more T cells (Fig. 2L). This evidence concerns the gene CXCL10 and neoplasm.